AI Lifecycle Marketing for Biotech & Pharma

The Lifecycle Marketing challenge for Biotech & Pharma

The MLR bottleneck is the defining pain. Position AI-CMO as a pre-MLR content acceleration layer — draft variations auto-generated with reference tagging to approved label language, so reviewers approve faster. Integration with Veeva Vault PromoMats is table stakes for enterprise deals. Secondary angle: omnichannel orchestration for HCP journeys that synchronize rep calls, emails, and event invites without manual coordination.

On Lifecycle Marketing specifically, Biotech & Pharma teams run into: Medical, Legal, Regulatory (MLR) review queues create 4–8 week delays that make campaigns stale before they launch; HCP segmentation is done manually in Excel — field reps don't have actionable, data-driven targeting for their territories; Congress season (ASCO, ADA, ACC) creates content demand spikes that small medical affairs teams cannot absorb; Patient support programs are marketed reactively rather than through proactive lifecycle journeys; KOL engagement tracking is scattered across MSL notes, CRM fields, and email threads with no unified view; Brand teams in different therapeutic areas duplicate research and creative work with no shared asset library. FDA 21 CFR Part 202 (prescription drug advertising); FDA guidance on social media and internet promotion; OPDP fair balance requirements; EFPIA Code (EU); PhRMA Code on interactions with HCPs; HIPAA for patient data; MLR approval documentation must be retained; off-label promotion prohibition is absolute

How CoMo's Lifecycle Marketing Agent runs Lifecycle Marketing for Biotech & Pharma

AI calculates churn risk scores and fires interventions the moment a signal appears — human CSMs only see accounts that have already churned. The agent reads CRM lifecycle and deal stage data (HubSpot / Salesforce), Product analytics (Mixpanel / Amplitude — feature usage, session frequency, last login), Email engagement history (opens, clicks, unsubscribes), Support ticket history (Zendesk / Intercom — ticket volume and sentiment) and runs: Maintain a real-time lifecycle stage model (MQL, SQL, trial, active, at-risk, churned) per contact; Trigger stage-appropriate nurture sequences automatically on stage transitions; Score contacts for churn risk using product usage, login recency, and support ticket signals; Route high-intent signals (pricing page visits, demo requests) to sales with context briefing; Run win-back sequences for churned or lapsed contacts at configurable re-engagement windows; Produce cohort retention analysis (week-1, week-4, week-12) for each signup cohort — applied to Biotech & Pharma context.

For Biotech & Pharma that means coordinated execution across HCP email, med-ed portals, LinkedIn, congresses/events, speaker programs, rep-triggered digital, patient advocacy partnerships without adding headcount, with a human approval gate before anything publishes or spends.

What you get

Outputs: Live lifecycle stage roster with stage-transition timestamps, Churn risk score per active account (daily refresh), Cohort retention curves (monthly report), Sales routing alerts for high-intent signals with behavioral context — tuned to Biotech & Pharma buyers (VP Commercial Marketing at mid-size pharma; Director of Marketing Excellence at specialty biotech; Head of Omnichannel at large pharma) and moving Net revenue retention (NRR %), Trial-to-paid conversion rate, Churn rate (monthly, by cohort). The Lifecycle Marketing Agent works alongside CoMo's other agents so Lifecycle Marketing stays aligned with the rest of your marketing.

RELATED